Related Experiment Videos
Modelling the P2Y purinoceptor using rhodopsin as template
A M Van Rhee1, B Fischer, P J Van Galen
1NIH, NIDDK, LBC, Molecular Recognition Section, Bethesda, Maryland 20892-0810, USA.
Drug Design and Discovery
|November 1, 1995
Summary
Researchers modeled the P2Y1 purinoceptor to understand ligand binding. Key residues and potential binding sites for adenosine 5'-triphosphate (ATP) were identified, aiding drug design for G-protein coupled receptors.
Area of Science:
- Molecular biology
- Biochemistry
- Pharmacology
Background:
- The P2Y1 purinoceptor is a G-protein coupled receptor (GPCR) crucial for various physiological processes.
- Understanding ligand binding is essential for developing targeted therapeutics.
Purpose of the Study:
- To construct a molecular model of the chick brain P2Y1 purinoceptor.
- To identify residues involved in ligand recognition and binding.
Main Methods:
- Homology modeling based on rhodopsin structure.
- Molecular dynamics simulations using the Amber forcefield.
- Docking of adenosine 5 omino-triphosphate (ATP) derivatives.
Main Results:
- Identified conserved residues facing the internal ligand-binding cleft.
- Proposed four basic residues (H121, H266, K269, R299) potentially coordinating ATP.
- N6-phenylethyl substituent docks in an aromatic pocket; N6,N6-dimethyl-ATP shows reduced activity due to Q296 interference.
Conclusions:
- The molecular model provides insights into P2Y1 purinoceptor ligand interactions.
- Identified key residues and binding site features for agonist recognition.
- The findings support structure-based drug design for P2Y1 receptor modulators.